DOCS vs VRSN
Doximity, Inc. and Verisign Inc/ca, side by side — 7 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | DOCS | VRSN |
|---|---|---|
| Revenue | $644.9M | $1.7B |
| Net income | $196.1M | $825.7M |
| Gross margin | 89.1% | 88.2% |
| Net margin | 30.4% | 49.8% |
| Return on equity | 19.3% | 48.6% |
| Diluted EPS | — | $6.24 |
| Dividend / share | — | $2.31 |
| Payout ratio | — | 26.1% |
| Free cash flow | $326.5M | $1.1B |
| Equity | $950.8M | $-2.2B |
| Net debt / equity | — | — |
| Current ratio | 6.09× | 0.49× |
| Revenue CAGR 5y | 25.5% | 5.5% |
| Profit CAGR 5y | 31.3% | 0.3% |
VRSN bills 2.6× the revenue of DOCS, and keeps more of each dollar of revenue as profit (49.8% against 30.4%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
7 years side by side
| Fiscal year | DOCS | VRSN |
|---|---|---|
| FY2025 | $644.9M | $1.7B |
| FY2024 | $570.4M | $1.6B |
| FY2023 | $475.4M | $1.5B |
| FY2022 | $419.1M | $1.4B |
| FY2021 | $343.5M | $1.3B |
| FY2020 | $206.9M | $1.3B |
| FY2019 | $116.4M | $1.2B |
Net income by year
Bottom line
| Fiscal year | DOCS | VRSN |
|---|---|---|
| FY2025 | $196.1M | $825.7M |
| FY2024 | $223.2M | $785.7M |
| FY2023 | $147.6M | $817.6M |
| FY2022 | $112.8M | $673.8M |
| FY2021 | $154.8M | $784.8M |
| FY2020 | $50.2M | $814.9M |
| FY2019 | $29.7M | $612.3M |
Advertisement
AdSense · Rectangle 336×280
More in this industry